Hematology and Blood Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Hematology and Blood Disorders 44 7897 074717

HIV And TB Co-infection

AIDS Care addresses the psychosocial aspects of AIDS through research in disciplines such as psychology, sociology, epidemiology, social work, ethics, education, etc.This journal highlights existing theoretical models of AIDS education and prevention, including model development, implementation, and evaluation.The scope of the journal highlights the advanced topics in drug development, HIV vaccines, pre-exposure prophylaxis, or post-exposure prophylaxis, Post-exposure prophylaxis, Sex Education, HIV/AIDS Denialism, AIDS Dementia Complex, rural livelihoods, stigma, patient oriented research studies.The Journal of HIV and AIDS (JHA) focuses on remarkable advances in our understanding of HIV science and its clinical evolution and management alternatives, comprising anti-retroviral and palliative therapies, and public health policies to contain the viral spread. The Journal editors are particularly interested in the latest breakthroughs in the diagnosis and therapy of HIV/AIDS immunological syndrome.Besides, the editors are interested in the practical application of the current understanding of that knowledge to clinical practice and the challenges to deliver those to the public.

All analyses were performed using SPSS software version 19.0 and findings were compared using the appropriate statistical tests. The median change from baseline to the most recent CD4 cell count was 141 cells/μl. By 5 years, the overall median CD4 cell count was 472 cells/μl while the median CD4 cell count was 401 cells/μl among patients with baseline CD4 cell counts ≤100 cells/μl, 467 cells/μl among those with baseline CD4 cell counts of 100 to 199 cells/μl, and 586 cells/μl among those with baseline CD4 cell counts equal to greater 200 cells/μl. At the end of the study, patients with higher baseline CD4 cell stratum returned to normal CD4 cell counts compared to those with the least baseline CD4 cell stratum. The findings suggest that consideration be given to initiation of ART at a CD4 cell count >350 cells/μl to achieve better immune recovery.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Get the App